Detalhe da pesquisa
1.
Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia.
Cell
; 173(6): 1439-1453.e19, 2018 05 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-29856956
2.
Decade-long leukaemia remissions with persistence of CD4+ CAR T cells.
Nature
; 602(7897): 503-509, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35110735
3.
Good CARMA: Turning bad tumor-resident myeloid cells good with chimeric antigen receptor macrophages.
Immunol Rev
; 320(1): 236-249, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37295964
4.
Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma.
Cell
; 142(5): 699-713, 2010 Sep 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-20813259
5.
Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia.
Haematologica
; 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38634143
6.
Real-world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemia.
Am J Hematol
; 98(8): 1254-1264, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37334852
7.
Author Correction: Decade-long leukaemia remissions with persistence of CD4+ CAR T cells.
Nature
; 612(7941): E22, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36477542
8.
Prediction and validation of hematopoietic stem and progenitor cell off-target editing in transplanted rhesus macaques.
Mol Ther
; 30(1): 209-222, 2022 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34174439
9.
One versus two sets of busulfan therapeutic drug monitoring in myeloablative allogeneic hematopoietic cell transplant.
J Oncol Pharm Pract
; : 10781552231189199, 2023 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37603585
10.
A cellular antidote to specifically deplete anti-CD19 chimeric antigen receptor-positive cells.
Blood
; 135(7): 505-509, 2020 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31703119
11.
Day 4 vs. day 12 G-CSF administration following reduced intensity peripheral blood allogeneic stem cell transplant.
J Oncol Pharm Pract
; 28(4): 892-897, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35191732
12.
Longitudinal Large-Scale Semiquantitative Proteomic Data Stability Across Multiple Instrument Platforms.
J Proteome Res
; 20(11): 5203-5211, 2021 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34669412
13.
Advances in chimeric antigen receptor T cells.
Curr Opin Hematol
; 27(6): 368-377, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32925186
14.
Nonviral RNA chimeric antigen receptor-modified T cells in patients with Hodgkin lymphoma.
Blood
; 132(10): 1022-1026, 2018 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29925499
15.
Risk of invasive fungal infections in patients with high-risk MDS and AML receiving hypomethylating agents.
Am J Hematol
; 95(7): 792-798, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32242967
16.
Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients.
Clin Infect Dis
; 68(12): 2003-2009, 2019 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30256954
17.
Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 25(3): e76-e85, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30576834
18.
Epigenetic engineering empowers T cells.
Blood
; 139(14): 2091-2092, 2022 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35389443
19.
Optimized depletion of chimeric antigen receptor T cells in murine xenograft models of human acute myeloid leukemia.
Blood
; 129(17): 2395-2407, 2017 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28246194
20.
Going viral: chimeric antigen receptor T-cell therapy for hematological malignancies.
Immunol Rev
; 263(1): 68-89, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25510272